Tapewire

Nasdaq · USD

VNDA

Vanda Pharmaceuticals Inc.

Export transactions ↓
Tapewire entity
5861
SEC CIK
0001347178
Parsed reports
233

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202601
Mar 202605
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 03, 2023 Filed Mar 6, 2023 23:25 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
SaleCommon Stock 22,538 $6.25 $140,876.02
Disclosure

SEC source: 0001209191-23-016462 · doc4.xml · nonDerivative · entry 2

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,476,902

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.20 to $6.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 18:25 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
SaleCommon Stock 7,966 $6.26 $49,845.65
Disclosure

SEC source: 0001209191-23-016461 · doc4.xml · nonDerivative · entry 1

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,894

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.24 to $6.2721, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:26 UTC
Williams TimothySVP & General Counsel
SaleCommon Stock 8,437 $6.24 $52,684.85
Disclosure

SEC source: 0001209191-23-016464 · doc4.xml · nonDerivative · entry 1

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,814

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.2327 to $6.265, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 18:24 UTC
Birznieks GuntherSVP, Business Development
SaleCommon Stock 8,509 $6.20 $52,793.24
Disclosure

SEC source: 0001209191-23-016460 · doc4.xml · nonDerivative · entry 1

Birznieks Gunther · CIK 0001702031 · SVP, Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 214,248

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.1901 to $6.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:26 UTC
Wijkstrom JoakimSVP, Chief Marketing Officer
SaleCommon Stock 7,720 $6.23 $48,122.62
Disclosure

SEC source: 0001209191-23-016463 · doc4.xml · nonDerivative · entry 1

Wijkstrom Joakim · CIK 0001785888 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,653

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.2201 to $6.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:25 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
SaleCommon Stock 22,426 $6.23 $139,718.47
Disclosure

SEC source: 0001209191-23-016462 · doc4.xml · nonDerivative · entry 1

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,499,440

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.21 to $6.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 18:09 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
GrantStock Option (Right to Buy) · Derivative 77,500 $0.00 Strike: $7.05 $0.00
Disclosure

SEC source: 0001209191-23-011340 · doc4.xml · derivative · entry 3

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 77,500 shares

Expires 2033-02-15

F2 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 16, 2024, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 18:09 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
GrantCommon Stock 32,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011340 · doc4.xml · nonDerivative · entry 1

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,860

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2024, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 23:11 UTC
Williams TimothySVP & General Counsel
GrantStock Option (Right to Buy) · Derivative 77,500 $0.00 Strike: $7.05 $0.00
Disclosure

SEC source: 0001209191-23-011343 · doc4.xml · derivative · entry 2

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 77,500 shares

Expires 2033-02-15

F2 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 16, 2024, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 23:11 UTC
Williams TimothySVP & General Counsel
GrantCommon Stock 32,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011343 · doc4.xml · nonDerivative · entry 1

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,251

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2024, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 18:08 UTC
Birznieks GuntherSVP, Business Development
GrantStock Option (Right to Buy) · Derivative 77,500 $0.00 Strike: $7.05 $0.00
Disclosure

SEC source: 0001209191-23-011338 · doc4.xml · derivative · entry 2

Birznieks Gunther · CIK 0001702031 · SVP, Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 77,500 shares

Expires 2033-02-15

F2 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 16, 2024, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 18:08 UTC
Birznieks GuntherSVP, Business Development
GrantCommon Stock 32,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011338 · doc4.xml · nonDerivative · entry 1

Birznieks Gunther · CIK 0001702031 · SVP, Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 222,757

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2024, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 23:11 UTC
Wijkstrom JoakimSVP, Chief Marketing Officer
GrantStock Option (Right to Buy) · Derivative 77,500 $0.00 Strike: $7.05 $0.00
Disclosure

SEC source: 0001209191-23-011342 · doc4.xml · derivative · entry 2

Wijkstrom Joakim · CIK 0001785888 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 77,500 shares

Expires 2033-02-15

F2 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 16, 2024, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 23:11 UTC
Wijkstrom JoakimSVP, Chief Marketing Officer
GrantCommon Stock 32,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011342 · doc4.xml · nonDerivative · entry 1

Wijkstrom Joakim · CIK 0001785888 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,373

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2024, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 23:10 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
GrantStock Option (Right to Buy) · Derivative 275,000 $0.00 Strike: $7.05 $0.00
Disclosure

SEC source: 0001209191-23-011341 · doc4.xml · derivative · entry 2

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,000

Underlying: Common Stock · 275,000 shares

Expires 2033-02-15

F2 · derivative.exercise_date: The option vests with respect to 25% of the underlying shares on February 16, 2024, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 23:10 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
GrantCommon Stock 115,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011341 · doc4.xml · nonDerivative · entry 1

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,521,866

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2024, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Read SEC document
December 15, 2022 Filed Dec 16, 2022 21:38 UTC
Williams TimothySVP & General Counsel
SaleCommon Stock 8,000 $7.01 $56,069.60
Disclosure

SEC source: 0001209191-22-061673 · doc4.xml · nonDerivative · entry 1

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,551

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.946 to $7.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
December 06, 2022 Filed Dec 7, 2022 17:56 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
Exercise / conversionStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $3.12 $0.00
Disclosure

SEC source: 0001209191-22-060225 · doc4.xml · derivative · entry 4

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2022-12-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option fully vested and exercisable.

Read SEC document
December 06, 2022 Filed Dec 7, 2022 17:56 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
SaleCommon Stock 4,792 $10.61 $50,826.83
Disclosure

SEC source: 0001209191-22-060225 · doc4.xml · nonDerivative · entry 2

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,160

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 6, 2022 as reflected in this Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.60 to $10.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
December 06, 2022 Filed Dec 7, 2022 17:56 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
Exercise / conversionCommon Stock 7,500 $3.12 $23,400.00
Disclosure

SEC source: 0001209191-22-060225 · doc4.xml · nonDerivative · entry 1

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,952

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2022 Filed Dec 7, 2022 22:58 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
Exercise / conversionStock Option (Right to Buy) · Derivative 75,365 $0.00 Strike: $3.12 $0.00
Disclosure

SEC source: 0001209191-22-060227 · doc4.xml · derivative · entry 6

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 75,635 shares

Expires 2022-12-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option fully vested and exercisable.

Read SEC document
December 06, 2022 Filed Dec 7, 2022 22:58 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
SaleCommon Stock 48,250 $10.61 $512,082.08
Disclosure

SEC source: 0001209191-22-060227 · doc4.xml · nonDerivative · entry 4

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,406,866

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 6, 2022 as reflected in this Form 4.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.39 to $10.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
December 06, 2022 Filed Dec 7, 2022 22:58 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
Exercise / conversionCommon Stock 75,365 $3.12 $235,138.80
Disclosure

SEC source: 0001209191-22-060227 · doc4.xml · nonDerivative · entry 3

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,455,116

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 05, 2022 Filed Dec 7, 2022 22:58 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
Exercise / conversionStock Option (Right to Buy) · Derivative 74,635 $0.00 Strike: $3.12 $0.00
Disclosure

SEC source: 0001209191-22-060227 · doc4.xml · derivative · entry 5

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,365

Underlying: Common Stock · 74,635 shares

Expires 2022-12-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option fully vested and exercisable.

Read SEC document
December 05, 2022 Filed Dec 7, 2022 22:58 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
SaleCommon Stock 47,650 $10.62 $506,200.25
Disclosure

SEC source: 0001209191-22-060227 · doc4.xml · nonDerivative · entry 2

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,379,751

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 6, 2022 as reflected in this Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.43 to $10.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
December 05, 2022 Filed Dec 7, 2022 22:58 UTC
Polymeropoulos Mihael HristosDirector · President and CEO · Chairman of the Board
Exercise / conversionCommon Stock 74,635 $3.12 $232,861.20
Disclosure

SEC source: 0001209191-22-060227 · doc4.xml · nonDerivative · entry 1

Polymeropoulos Mihael Hristos · CIK 0001355537 · Director · President and CEO · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,427,401

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 26, 2022 Filed Aug 29, 2022 17:02 UTC
Birznieks GuntherSVP, Business Development
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,250 $0.00 Strike: $3.12 $0.00
Disclosure

SEC source: 0001209191-22-047887 · doc4.xml · derivative · entry 2

Birznieks Gunther · CIK 0001702031 · SVP, Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,250 shares

Expires 2022-12-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested in 48 equal monthly installments beginning on December 7, 2012.

Read SEC document
August 26, 2022 Filed Aug 29, 2022 17:02 UTC
Birznieks GuntherSVP, Business Development
Exercise / conversionCommon Stock 1,250 $3.12 $3,900.00
Disclosure

SEC source: 0001209191-22-047887 · doc4.xml · nonDerivative · entry 1

Birznieks Gunther · CIK 0001702031 · SVP, Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,057

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 22, 2022 Filed Aug 23, 2022 21:01 UTC
Wijkstrom JoakimSVP, Chief Marketing Officer
SaleCommon Stock 3,605 $10.27 $37,007.49
Disclosure

SEC source: 0001209191-22-047210 · doc4.xml · nonDerivative · entry 1

Wijkstrom Joakim · CIK 0001785888 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,673

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 20:06 UTC
Williams TimothySVP & General Counsel
SaleCommon Stock 4,611 $10.21 $47,064.94
Disclosure

SEC source: 0001209191-22-046228 · doc4.xml · nonDerivative · entry 2

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,551

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.20 to $10.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
August 15, 2022 Filed Aug 17, 2022 20:06 UTC
Williams TimothySVP & General Counsel
SaleCommon Stock 3,689 $10.42 $38,439.38
Disclosure

SEC source: 0001209191-22-046228 · doc4.xml · nonDerivative · entry 1

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,162

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

Read SEC document
July 28, 2022 Filed Aug 1, 2022 16:45 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
SaleCommon Stock 2,239 $10.97 $24,561.83
Disclosure

SEC source: 0001209191-22-043682 · doc4.xml · nonDerivative · entry 1

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,452

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 20:54 UTC GrantStock Option (Right to Buy) · Derivative 24,707 $0.00 Strike: $9.37 $0.00
Disclosure

SEC source: 0001209191-22-038447 · doc4.xml · derivative · entry 2

DUGAN RICHARD W · CIK 0001263499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,707

Underlying: Common Stock · 24,707 shares

Expires 2032-06-15

F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 20:54 UTC GrantCommon Stock 12,006 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-038447 · doc4.xml · nonDerivative · entry 1

DUGAN RICHARD W · CIK 0001263499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,393

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 20:55 UTC GrantStock Option (right to buy) · Derivative 24,707 $0.00 Strike: $9.37 $0.00
Disclosure

SEC source: 0001209191-22-038449 · doc4.xml · derivative · entry 2

Ward Anne Sempowski · CIK 0001790117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,707

Underlying: Common Stock · 24,707 shares

Expires 2032-06-15

F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 20:55 UTC GrantCommon Stock 12,006 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-038449 · doc4.xml · nonDerivative · entry 1

Ward Anne Sempowski · CIK 0001790117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,006

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 20:55 UTC GrantStock Option (right to buy) · Derivative 24,707 $0.00 Strike: $9.37 $0.00
Disclosure

SEC source: 0001209191-22-038448 · doc4.xml · derivative · entry 2

Mitchell Stephen Ray · CIK 0001802653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,707

Underlying: Common Stock · 24,707 shares

Expires 2032-06-15

F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 20:55 UTC GrantCommon Stock 12,006 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-038448 · doc4.xml · nonDerivative · entry 1

Mitchell Stephen Ray · CIK 0001802653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,521

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 20:53 UTC GrantStock Option (Right to Buy) · Derivative 24,707 $0.00 Strike: $9.37 $0.00
Disclosure

SEC source: 0001209191-22-038446 · doc4.xml · derivative · entry 2

Chrousos Phaedra · CIK 0001774518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,707

Underlying: Common Stock · 24,707 shares

Expires 2032-06-15

F2 · derivative.exercise_date: This option vests and becomes exercisable with respect to 100% of the option shares on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 20:53 UTC GrantCommon Stock 12,006 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-038446 · doc4.xml · nonDerivative · entry 1

Chrousos Phaedra · CIK 0001774518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,931

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Read SEC document
June 13, 2022 Filed Jun 15, 2022 00:37 UTC SaleCommon Stock 2,700 $9.48 $25,593.03
Disclosure

SEC source: 0001209191-22-036835 · doc4.xml · nonDerivative · entry 1

Mitchell Stephen Ray · CIK 0001802653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,515

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.431 to $9.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 16:31 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $4.15 $0.00
Disclosure

SEC source: 0001209191-22-034062 · doc4.xml · derivative · entry 3

Watkins Thomas · CIK 0001307935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2022-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested in 12 equal monthly installments beginning on July 14, 2012.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 16:31 UTC SaleCommon Stock 6,441 $9.90 $63,778.78
Disclosure

SEC source: 0001209191-22-034062 · doc4.xml · nonDerivative · entry 2

Watkins Thomas · CIK 0001307935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,064

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy the exercise price of the stock options, which were scheduled to expire June 13, 2022 as reflected in this Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.90 to $9.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 16:31 UTC Exercise / conversionCommon Stock 15,000 $4.15 $62,250.00
Disclosure

SEC source: 0001209191-22-034062 · doc4.xml · nonDerivative · entry 1

Watkins Thomas · CIK 0001307935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,505

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 31, 2022 Filed Jun 2, 2022 20:47 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $4.15 $0.00
Disclosure

SEC source: 0001209191-22-033561 · doc4.xml · derivative · entry 3

DUGAN RICHARD W · CIK 0001263499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2022-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested in 12 equal monthly installments beginning on July 14, 2012.

Read SEC document
May 31, 2022 Filed Jun 2, 2022 20:47 UTC SaleCommon Stock 6,500 $9.85 $64,052.30
Disclosure

SEC source: 0001209191-22-033561 · doc4.xml · nonDerivative · entry 2

DUGAN RICHARD W · CIK 0001263499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,387

F1 · kind: Represents shares of the Issuer's common stock sold to satisfy the exercise price of the stock options, which were scheduled to expire June 13, 2022 as reflected in this Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $9.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
May 31, 2022 Filed Jun 2, 2022 20:47 UTC Exercise / conversionCommon Stock 15,000 $4.15 $62,250.00
Disclosure

SEC source: 0001209191-22-033561 · doc4.xml · nonDerivative · entry 1

DUGAN RICHARD W · CIK 0001263499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,887

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2022 Filed Mar 2, 2022 21:27 UTC
Moran Kevin PatrickSVP, CFO & Treasurer
SaleCommon Stock 8,832 $11.28 $99,649.69
Disclosure

SEC source: 0001209191-22-015155 · doc4.xml · nonDerivative · entry 3

Moran Kevin Patrick · CIK 0001806596 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,691

F2 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.18 to $11.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 02:29 UTC
Williams TimothySVP & General Counsel
SaleCommon Stock 12,060 $11.09 $133,779.17
Disclosure

SEC source: 0001209191-22-015160 · doc4.xml · nonDerivative · entry 2

Williams Timothy · CIK 0001748392 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,851

F2 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.03 to $11.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
March 02, 2022 Filed Mar 2, 2022 21:26 UTC
Birznieks GuntherSVP, Business Development
SaleCommon Stock 11,517 $11.27 $129,791.98
Disclosure

SEC source: 0001209191-22-015154 · doc4.xml · nonDerivative · entry 3

Birznieks Gunther · CIK 0001702031 · SVP, Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,807

F2 · kind: Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.20 to $11.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.